Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment

SIMPLE SUMMARY: The global impact of the current COVID-19 pandemic has led to the impressively rapid development of multiple anti-SARS-CoV-2 vaccines. However, only few data are available regarding the efficacy of anti-SARS-CoV-2 vaccines in patients with hematological malignancies, and, in particul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghandili, Susanne, Schönlein, Martin, Lütgehetmann, Marc, Schulze zur Wiesch, Julian, Becher, Heiko, Bokemeyer, Carsten, Sinn, Marianne, Weisel, Katja C., Leypoldt, Lisa B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345197/
https://www.ncbi.nlm.nih.gov/pubmed/34359701
http://dx.doi.org/10.3390/cancers13153800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345197/
https://www.ncbi.nlm.nih.gov/pubmed/34359701
http://dx.doi.org/10.3390/cancers13153800

Ejemplares similares